Overview
Lactococcus lactis is a Gram-positive, homofermentative lactic acid bacterium that holds a central position in dairy microbiology as the primary starter culture for cheese and fermented milk production worldwide. Beyond its industrial significance, L. lactis has emerged as a versatile probiotic species with documented antimicrobial, anti-inflammatory, and immunomodulatory properties. The species is perhaps best known for its production of nisin, a naturally occurring antimicrobial peptide that is one of the few bacteriocins approved for food use globally.
In recent years, L. lactis has also attracted attention as a biological delivery vehicle for therapeutic proteins, with engineered strains capable of delivering anti-inflammatory cytokines directly to the gut mucosa — a pioneering approach to treating inflammatory bowel disease.
Classification
L. lactis belongs to the family Streptococcaceae within the order Lactobacillales, phylum Bacillota (formerly Firmicutes). It is a Gram-positive, non-motile, non-spore-forming coccus that occurs in pairs or short chains. The species includes two major subspecies: subsp. lactis and subsp. cremoris, both widely used in dairy fermentation. Reference genome strains include MG1363, IL1403, and NZ9000, the latter being the standard host for the NICE (Nisin-Controlled Expression) system used extensively in molecular biology research.
Key Characteristics
The most notable characteristic of L. lactis is its production of nisin, a lantibiotic bacteriocin with broad-spectrum activity against Gram-positive bacteria. Nisin creates pores in bacterial cell membranes and also inhibits cell wall synthesis, making it effective against a range of pathogens. This natural antimicrobial capacity extends to competitive exclusion of enteric pathogens, with studies demonstrating that L. lactis strains may reduce adhesion of enteroinvasive E. coli by up to 90.5% and Salmonella Typhimurium by 76-91%.
The species also demonstrates the ability to inhibit Salmonella motility through acetate-mediated flagellar disruption, adding a mechanistic dimension to its pathogen exclusion capabilities. Additionally, L. lactis performs efficient lactose fermentation, contributing to improved lactose tolerance when consumed through fermented dairy products.
Health Significance
The health significance of L. lactis spans antimicrobial, immune, and therapeutic delivery applications. Its strong competitive exclusion of enteric pathogens suggests potential value in preventing foodborne infections and supporting gut health during periods of microbial challenge. Intranasal administration of strain W136 has shown immunomodulatory effects in early SARS-CoV-2 infection in proof-of-concept studies, though further clinical validation is needed.
Perhaps most groundbreaking is the use of engineered L. lactis as a biological delivery vehicle. Landmark research demonstrated that L. lactis engineered to secrete interleukin-10 (IL-10) effectively treated inflammatory bowel disease in murine colitis models, establishing the species as a platform for delivering therapeutic proteins directly to the gut mucosa. While these bioengineered applications remain primarily in research settings, they highlight the unique potential of L. lactis as both a traditional probiotic and a next-generation therapeutic delivery system.